Journal: EMBO Molecular Medicine
Article Title: In vitro and in vivo inhibition of the host TRPC4 channel attenuates Zika virus infection
doi: 10.1038/s44321-024-00103-4
Figure Lengend Snippet: ( A ) Survival rates of ZIKV-infected BHK cells were increased in the HC-070 (10 μM), EGTA (1 mM, the extracellular calcium chelating agent), and KN-93 (10 μM, CaMKII inhibitor) treatment groups ( n = 5–7 biological replicates). ( B ) Representative images (left) and summary data (right) of ZIKV- or mock-infected BHK cells immunoassayed for the ZIKV E protein (red). The cells were pretreated with DMSO, HC-070 (10 μM), EGTA (1 mM), or KN-93 (10 μM). The fluorescence intensity (F) was quantified using ImageJ software, and the obtained data were compared in the right panel ( n = 4–6 biological replicates). The scale bar represents 50 μm. ( C ) Western blots were performed to detect and quantify the production of ZIKV-NS1 proteins (NS1) in KN-93 (10 μM) or HC-070 (10 μM) pretreated BHK cells infected with ZIKV ( n = 4 biological replicates). ( D ) Viral replication was quantified by counting infectious viral particles isolated from the supernatants of BHK cells infected with ZIKV and treated with either DMSO (vehicle control), HC-070 (10 μM), or KN-93 (10 μM). Infectious viral particles were detected using the viral plaque-forming unit assay ( n = 4 biological replicates). ( E ) Representative immunoblot images showing a decrease of TRPC4 protein levels in KN-93-treated BHK cells without ZIKV infection. ( F ) Co-immunoprecipitation (Co-IP) assays are shown. Whole-cell extracts from ZIKV-NS3 overexpressed BHK cells were subjected to immunoprecipitation (IP) using either anti-NS3 or anti-CaMKII antibody. The co-immunoprecipitated proteins were subsequently detected by western blotting using specific antibodies against CaMKII or NS3. ( G ) The graph shows that ZIKV-infected neonatal mouse brains exhibit an enhanced immunofluorescence staining of pCREB ( n = 4 mice) compared to mock-infected mice. ( H ) Western blot analysis was performed to detect (left) and quantify (right) the phosphorylation level of CREB (pCREB) relative to total CREB in KN-93 (10 μM) or HC-070 (10 μM) pretreated BHK cells infected with ZIKV ( n = 5 biological replicates). ( I – L ) Representative immunoblot images show the efficacy of siRNA-mediated knockdown of the ZIKV-NS1 protein production in ZIKV-infected BHK cells ( n = 4 biological replicates). Prior to ZIKV challenge (MOI 0.01), cells were transfected with scRNAs or siRNAs targeting CaMKII ( I , J ) or CREB ( K , L ) for a duration of 48 h ( n = 4 biological replicates). ( M ) Shown are the changes in normalized R-GECO fluorescence (F/F o ) induced by Gd 3+ (100 μM) in TRPC4 (black line), NS3 (green line), or TRPC4 + NS3 (red line)-expressing cells. Intracellular Ca 2+ levels were monitored using the R-GECO biosensor. Cells were transfected with the indicated cDNAs. The horizontal bar shows the times when Gd 3+ was added to the wells with cells. The right panel displays a comparison of normalized R-GECO fluorescence increases in each tested group ( n = 9–12, 3–4 wells were for each experiment, with three biological replicates). The unpaired T test (two-tailed) and one-way ANOVA followed by the Dunnett’s test as the post hoc were employed to determine if there was a significant difference between two groups or among multiple groups, respectively. Data information: In ( A – D , G , H , J , L , M ), data are presented as mean ± SEM, * P ≤ 0.05, ** P ≤ 0.01, *** P ≤ 0.001. .
Article Snippet: The R-GECO Red Fluorescent Ca 2+ Assay was purchased from Montana Molecular (#U0600R, Bozeman, MT, USA), and the BHK cells were transfected with the R-GECO sensor plasmid according to the manufacturer’s instructions.
Techniques: Infection, Fluorescence, Software, Western Blot, Isolation, Control, Immunoprecipitation, Co-Immunoprecipitation Assay, Immunofluorescence, Staining, Phospho-proteomics, Knockdown, Transfection, Expressing, Comparison, Two Tailed Test